Industry consultants Frost & Sullivan are 100% involved, and the Hong Kong Stock Exchange witnessed another day of four companies ringing the gong simultaneously

All four companies have chosen Frost & Sullivan (Frost & Sullivan, abbreviated as: Frost & Sullivan) as their trusted partner, providing them with exclusive industry advisory services! We cherish and are grateful for the choices and trust of our customers, and we will live up to our commitments by continuing to accompany more companies in achieving higher-quality development in the capital market with professional services!

Frost & Sullivan (Frost & Sullivan) has always been a leader in helping companies go public in Hong Kong, boasting rich industry experience and communication skills with regulatory authorities, exchanges, investment and financing institutions, and various related organizations. According to LiveReport's big data (statistical data as of December 31, 2025), from January to December 2025, as well as over a 36-month statistical period, Frost & Sullivan provided listing industry advisory services for 83 (market share of 72%) and 180 (market share of 71%) successful Hong Kong IPO companies, ranking first in terms of number.

Nanhua Futures Co., Ltd. (Stock Code: 2691.HK)

Nanhua Futures Co., Ltd.Positioned as a leading futures company in China, it provides futures and derivatives services both domestically and internationally by virtue of its in-depth understanding of the needs of Chinese and overseas clients, as well as its keen insight into the global financial and derivatives markets.

BenQ Healthcare Group Co., Ltd. (Stock Code: 2581.HK)

BenQ Healthcare Group Co., Ltd.It is a private for-profit comprehensive hospital group in the Chinese mainland, currently owning and operating two private for-profit comprehensive hospitals. Calculated based on total revenue in 2024, the company is the largest private for-profit comprehensive hospital group in East China, holding a market share of 1.0% in the region; by the same measure, it ranks seventh among all private for-profit comprehensive hospital groups nationwide, with a market share of 0.4% in China; calculated based on average bed income in 2024, the company ranks first among all private for-profit comprehensive hospital groups in mainland China.

Huafeng Biotechnology (Qingdao) Co., Ltd. (Stock Code: 2396.HK)

Huafeng Biotechnology (Qingdao) Co., Ltd.It is an innovative biopharmaceutical company focusing on wound healing and tissue repair. The company selects indications based on unmet clinical medical needs, deeply invests in the field of wound healing treatment, and takes platelet-derived growth factor (PDGF)-related drugs as the core R&D pipeline.

Impression Dahongpao Co., Ltd. (Stock Code: 2695.HK)

Impression Dahongpao Co., Ltd.is a leading cultural and tourism performance company in China, dedicated to building around local characteristic cultural resourcesImmersive cultural and tourism experienceThe business mainly includes performances and related services, the Impression Cultural Tourism Town business, and the Chaotang Hotel business.

During the process of an enterprise going public in Hong Kong, Frost & Sullivan mainly undertakes the following tasks: helping the issuer accurately and objectively understand its positioning in the target market, using objective market data to discover, support, and highlight the issuer's competitive advantages, assisting the issuer, investment banks, and other intermediaries in completing the relevant parts of the prospectus (such as the overview, competitive advantages and strategy, industry overview, business, and other important sections), helping the issuer complete communication with the Hong Kong Stock Exchange and investors, assisting investors in quickly understanding the market ecosystem and competitive landscape, and assisting the issuer in completing feedback on various industry-related issues from the Hong Kong Stock Exchange, etc.

Since the Frost & Sullivan team began providing investment and financing advisory services to corporate leaders and their management teams, it has helped nearly 3,000 companies successfully list on the Hong Kong stock market and overseas. It is a leading enterprise in the field of investment and financing strategy consulting in China. Frost & Sullivan has long cooperated closely with globally renowned investment banks, accounting firms, law firms, investment institutions, and industry-leading enterprises to build an efficient domestic investment and financing demand matching platform, enabling it to quickly form comprehensive consulting service teams. Over the past decade, Frost & Sullivan has consistently ranked first in the market share of professional industry consultants for Chinese companies listing on the Hong Kong stock market and overseas; moreover, in recent years, Frost & Sullivan reports have been widely cited in the prospectuses of leading A-share and science and technology innovation board listed companies, primary and secondary market research reports, and other capital market disclosure documents.